Psychogenic movement disorder after a venlafaxine-induced dystonia.
Fonseca
Luís
L
Rodrigues
Margarida
M
Machado
Alvaro
A
D000328:Adult; D000978:Antiparkinson Agents / Q000627:therapeutic use; D001712:Biperiden / Q000627:therapeutic use; D003511:Cyclohexanols / Q000009:adverse effects*; D004421:Dystonia / Q000139:chemically induced* / Q000188:drug therapy / Q000523:psychology*; D005260:Female; D006801:Humans; D009069:Movement Disorders / Q000209:etiology*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D000069470:Venlafaxine Hydrochloride
D000978:Antiparkinson Agents; D001712:Biperiden; D003511:Cyclohexanols; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride